University of Kentucky College of Medicine
Otolaryngology residency · Lexington, KY · University of Kentucky programs · Program website
Roster not collected yet. There's no list of this program's own faculty, trainees, or papers yet. Below is University of Kentucky's research in otolaryngology, which the program shares with other departments and affiliated hospitals.
Otolaryngology at University of Kentuckyshared by every program there, not this program's own
Institution-level: all otolaryngology publications from University of Kentucky and affiliated institutions, since 2022. Updated 2026-11-06; refreshed daily.
9
works per year
34th of 57 institutions with otolaryngology residencies
+64.3%
2-year growth
7th of 56 institutions with otolaryngology residencies
37.5%
in top 10% of field (works before 2025)
3rd of 40 institutions with otolaryngology residencies
54.2%
cited above world average
17th of 40 institutions with otolaryngology residencies
Works per year · * 2026 so far
Otorhinolaryngology · 46
Otolaryngology research topics at University of Kentucky
Papers in the window; each links to the list on OpenAlex.
Most cited at University of Kentucky since 2024
All otolaryngology papers there on OpenAlex
- Neoadjuvant Nivolumab plus Carboplatin and Paclitaxel in Patients with Locally Advanced Resectable Squamous Cell Carcinoma of the Head and Neck: A Phase II, Single-Arm TrialRalph Zinner et al. · Clinical Cancer Research · 2025 · PubMed · cited 7
- Functional Impact of Transoral Surgery and Risk-Based Adjuvant Therapy in Human Papillomavirus–Associated Oropharyngeal Cancer: Swallowing Outcomes From ECOG-ACRIN E3311Katherine A. Hutcheson et al. · JCO oncology advances. · 2025 · PubMed · cited 6
- Safety and Efficacy Findings From a Phase Ib/ II Study of ASP ‐1929 Photoimmunotherapy With Pembrolizumab in Recurrent and/or Metastatic Head and Neck Squamous Cell CarcinomaDavid M. Cognetti et al. · Head & Neck · 2025 · PubMed · cited 20
- Prevalence and biological impact of clinically relevant gene fusions in head and neck cancersEmily L. Hoskins et al. · npj Precision Oncology · 2025 · PubMed · cited 4
- A phase 3 randomized study of ASP-1929 photoimmunotherapy in combination with pembrolizumab versus standard of care in locoregional recurrent head and neck squamous cell carcinoma (HNSCC).Anastasios Maniakas et al. · Journal of Clinical Oncology · 2025 · cited 5
- ACR Appropriateness Criteria® Inflammatory Ear DiseaseMohit Agarwal et al. · Journal of the American College of Radiology · 2025 · PubMed · cited 8
- Association between Locoregional Failure and NFE2L2/KEAP1/CUL3 Mutations in NRG/RTOG 9512: A Randomized Trial of Radiation Fractionation in T2N0 Glottic CancerLi Guan et al. · Clinical Cancer Research · 2024 · PubMed · cited 8
- 879P VERSATILE-002: Survival with first-line treatment with PDS0101 therapeutic vaccine and pembrolizumab in HPV16-positive recurrent/metastatic head and neck squamous cell carcinoma (HNSCC)J. Weiss et al. · Annals of Oncology · 2024 · cited 12
- Trends in Oral Tongue Cancer Incidence in the USTodd Burus et al. · JAMA Otolaryngology–Head & Neck Surgery · 2024 · PubMed · cited 29
- Assessing the feasibility of a multimodal liquid biopsy for the diagnosis of HPV-associated oropharyngeal squamous cell carcinomaJames S. Lewis et al. · American Journal of Clinical Pathology · 2024 · PubMed · cited 10
Add to your program's websitea badge, your paper list, a feed
For program directors and coordinators. Both update with the site and need no account.
Badge linking to this page
<a href="https://openprograms.org/programs/university-kentucky-college-medicine-ent"><img src="https://openprograms.org/programs/university-kentucky-college-medicine-ent/badge.svg" alt="University of Kentucky College of Medicine Otolaryngology residency on OpenPrograms" height="20"></a>Something wrong or missing on this page? Use the correction form below; changes show up in both.